SCHEMBL2556718

SCHEMBL2556718

COc1ccc(C=O)c2c1oc1ccncc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.39
CYP19A1 P11511 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
ERN1 O75460 3/20 0.36
PDE4A P27815 3/20 0.36
PDE4B Q07343 3/20 0.36
PDE4C Q08493 3/20 0.36
PDE4D Q08499 3/20 0.36
CYP1A1 P04798 3/20 0.36
CYP1B1 Q16678 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MAOA P21397 2/20 0.36
LMNA P02545 2/20 0.36
KDM4E B2RXH2 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CYP1A2 P05177 2/20 0.35
MAPT P10636 3/20 0.35
MGAM O43451 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2559970 0.90 IDO1 (0.39) CYP17A1CYP19A1CYP11B1CYP11B2ERN1
SCHEMBL13233338 0.87 PDE4A (0.36) PDE4APDE4BPDE4CPDE4D
SCHEMBL2562661 0.84 PDE4B (0.52) CYP17A1CYP19A1CYP11B1CYP11B2PDE4A
SCHEMBL7709222 0.83 SMN1; SMN2 (0.41) CYP17A1CYP19A1CYP11B1CYP11B2PDE4A
SCHEMBL1647979 0.81 MAOA (0.52) CYP17A1CYP19A1CYP11B1CYP11B2PDE4B
SCHEMBL2563005 0.79 CCNC (0.42) CYP1A1CYP1B1ALDH1A1LMNAKDM4E
SCHEMBL74295 0.78 PDE4B (0.46) CYP17A1CYP19A1CYP11B1CYP11B2PDE4A
SCHEMBL74252 0.77 PDE4B (0.46) CYP17A1CYP19A1CYP11B1CYP11B2PDE4A
SCHEMBL2556489 0.76 CYP19A1 (0.40) CYP19A1CYP11B1CYP11B2ALDH1A1LMNA
SCHEMBL3724543 0.75 MAOA (0.57) CYP17A1CYP19A1CYP11B1CYP11B2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed